(Q37845609)

English

Review series: Aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ?

scientific article published on January 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21339375%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

1 reference

Europe PubMed Central

Review series: Aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ? (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21339375%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

connective tissue

1 reference

based on heuristic

inferred from title

interstitial lung disease

1 reference

based on heuristic

inferred from title

Elisabetta Renzoni

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21339375%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

author name string

Angelo de Lauretis

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21339375%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Srihari Veeraraghavan

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21339375%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

publication date

1 January 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21339375%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Chronic Respiratory Disease

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21339375%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21339375%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21339375%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

53-82

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21339375%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Radiological versus histological diagnosis in UIP and NSIP: survival implications.

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

The accuracy of the clinical diagnosis of new-onset idiopathic pulmonary fibrosis and other interstitial lung disease: A prospective study

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Interstitial lung disease in systemic sclerosis: a simple staging system

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Rheumatoid arthritis-related lung diseases: CT findings

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Fibrosing alveolitis associated with systemic sclerosis has a better prognosis than lone cryptogenic fibrosing alveolitis.

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes.

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Diffuse alveolar damage: uncommon manifestation of pulmonary involvement in patients with connective tissue diseases.

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Rapidly progressive fatal interstitial lung disease in a patient with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Interstitial lung disease in primary Sjögren syndrome.

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

CT features of lung disease in patients with systemic sclerosis: comparison with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia.

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis.

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome.

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Fibroblastic foci in usual interstitial pneumonia: idiopathic versus collagen vascular disease.

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Pathologic and radiologic differences between idiopathic and collagen vascular disease-related usual interstitial pneumonia

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Pulmonary function tests in connective tissue disease

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Racial differences in scleroderma among women in Michigan

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Clinical manifestations of systemic sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Severe restrictive lung disease in systemic sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Cyclophosphamide versus placebo in scleroderma lung disease.

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease.

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Use of mycophenolate mofetil to treat scleroderma-associated interstitial lung disease

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Effect of mycophenolate mofetil on pulmonary function in scleroderma-associated interstitial lung disease.

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in France

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Clinical differences between idiopathic and scleroderma-related pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement.

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Ambrisentan for the treatment of pulmonary arterial hypertension: results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2.

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Sildenafil citrate therapy for pulmonary arterial hypertension

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Systemic sclerosis associated pulmonary hypertension: improved survival in the current era.

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Long-term outcome of systemic sclerosis-associated pulmonary arterial hypertension treated with bosentan as first-line monotherapy followed or not by the addition of prostanoids or sildenafil

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Risk factors for the development of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Rheumatoid arthritis (RA)-specific autoantibodies in patients with interstitial lung disease and absence of clinically apparent articular RA.

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Death rates and causes of death in patients with rheumatoid arthritis: a population-based study

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Interstitial lung disease in recent onset rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Cigarette smoking and rheumatoid arthritis severity

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Rheumatoid arthritis-associated interstitial lung disease: the relevance of histopathologic and radiographic pattern

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease.

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Methotrexate-related pulmonary complications in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Methotrexate-Induced Pulmonary Injury: Serial CT findings

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Leflunomide-related lung injury in patients with rheumatoid arthritis: imaging features

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Diffuse alveolar hemorrhage after leflunomide therapy in a patient with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Relationship of gold and penicillamine therapy to diffuse interstitial lung disease

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Sulphasalazine and lung toxicity

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Drug-induced alveolitis caused by salazosulfapyridine

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Pulmonary complications of tumor necrosis factor-targeted therapy

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Tolerability and safety of rituximab (MabThera).

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Safety of rituximab in the treatment of B cell malignancies: implications for rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Polymyositis and dermatomyositis

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Polymyositis and dermatomyositis (first of two parts)

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Polymyositis and dermatomyositis (second of two parts)

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Amyopathic dermatomyositis: a review by the Italian Group of Immunodermatology.

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

The respiratory system in connective tissue disorders

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Pulmonary complications of polymyositis and dermatomyositis

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Long-term survival of patients with idiopathic inflammatory myopathies according to clinical features: a longitudinal study of 162 cases

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Pulmonary disease in polymyositis/dermatomyositis: a clinicopathological analysis of 65 autopsy cases

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Pulmonary disease in polymyositis/dermatomyositis

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Interstitial lung disease, a common manifestation of newly diagnosed polymyositis and dermatomyositis

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Interstitial lung disease in amyopathic dermatomyositis, dermatomyositis and polymyositis

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Polymyositis/dermatomyositis-associated lung disease: analysis of a series of 81 patients

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Interstitial lung disease in polymyositis and dermatomyositis: Clinical course and response to treatment

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Two distinct clinical types of interstitial lung disease associated with polymyositis-dermatomyositis.

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Interstitial lung disease in polymyositis and dermatomyositis: longitudinal evaluation by pulmonary function and radiology

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Serial chest CT findings in interstitial lung disease associated with polymyositis-dermatomyositis.

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Polymyositis-dermatomyositis-associated interstitial lung disease

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Computed tomographic imaging in connective tissue diseases

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Antisynthetase syndrome

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Interstitial lung disease and anti-Jo-1 antibodies: difference between acute and gradual onset.

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Sequential changes of KL-6 in sera of patients with interstitial pneumonia associated with polymyositis/dermatomyositis

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Acute respiratory failure due to diaphragmatic weakness revealing a polymyositis.

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Recent advances in the treatment of interstitial lung disease in patients with polymyositis/dermatomyositis

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Management of fibrosing alveolitis with polymyositis dermatomyositis

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Rituximab treatment of the anti-synthetase syndrome: a retrospective case series

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Sjogren's syndrome is associated with and not secondary to systemic sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Sjögren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

The overlap of Sjögren's syndrome with other systemic autoimmune diseases

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Pulmonary lesions associated with Sjögren's syndrome: radiographic and CT findings.

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Ten year follow up of pulmonary function in patients with primary Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Primary Sjögren's syndrome in north east England--a longitudinal study

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Primary Sjögren syndrome in Spain: clinical and immunologic expression in 1010 patients

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Pulmonary arterial hypertension: a rare complication of primary Sjögren syndrome: report of 9 new cases and review of the literature

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Pulmonary manifestations of primary Sjogren's syndrome: a clinical, radiologic, and pathologic study

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Lung involvement in primary Sjögren's syndrome is mainly related to the small airway disease

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Nonspecific interstitial pneumonia as pulmonary involvement of primary Sjögren's syndrome.

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Pulmonary manifestations of Sjögren's syndrome.

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Increased Risk of Lymphoma in Sicca Syndrome

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Malignant lymphoma in primary Sjögren's syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sjögren's Syndrome

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Clinical and imaging findings of lymphoma in patients with Sjögren syndrome.

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Mortality and causes of death in primary Sjögren's syndrome: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Prevalence of adult systemic lupus erythematosus in California and Pennsylvania in 2000: estimates obtained using hospitalization data

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

The 1982 revised criteria for the classification of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Mortality in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

The epidemiology of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Respiratory manifestations of systemic lupus erythematosus: old and new concepts

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Systemic lupus erythematosus in a multiethnic US Cohort LUMINA XLVIII: factors predictive of pulmonary damage

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Thoracic involvement of systemic lupus erythematosus: clinical, pathologic, and radiologic findings

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Dyspnoea in a young woman with active systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

A multicentre study of 513 Danish patients with systemic lupus erythematosus. I. Disease manifestations and analyses of clinical subsets.

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Interstitial lung disease in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

A long-term study of interstitial lung disease in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Diffuse alveolar hemorrhage and systemic lupus erythematosus. Clinical presentation, histology, survival, and outcome

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Pulmonary alveolar hemorrhage in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Alveolar hemorrhage in systemic lupus erythematosus: presentation and management

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Intravenous immunoglobulin therapy of lupus pneumonitis

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Catastrophic antiphospholipid syndrome: where do we stand?

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Pulmonary involvement of systemic lupus erythematosus: analysis of 90 necropsies.

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Five-year follow-up study of the prevalence and progression of pulmonary hypertension in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Therapy with intermittent pulse cyclophosphamide for pulmonary hypertension associated with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Immunosuppressive therapy in lupus- and mixed connective tissue disease–associated pulmonary arterial hypertension: A retrospective analysis of twenty-three cases

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Rituximab treatment of pulmonary arterial hypertension associated with systemic lupus erythematosus: a case report

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease?

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Evaluation of interstitial lung disease in mixed connective tissue disease (MCTD).

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Treatment of idiopathic pulmonary fibrosis with etanercept: an exploratory, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

High-dose acetylcysteine in idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Pirfenidone in idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Use of intermittent, intravenous cyclophosphamide for idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Outcome of subjects with idiopathic pulmonary fibrosis who fail corticosteroid therapy. Implications for further studies

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

High-resolution CT imaging of the lung for patients with primary Sjögren’s syndrome

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37845609&oldid=1516247239"